Celldex Therapeutics, Inc.
CLDX US15117B2025
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 102% | 14% | -9% | -37% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Jimenez Freddy A. VP |
25.42 USD |
430 Sold |
10,928 USD |
13/08/2025 | 13/08/2025 |
| Jimenez Freddy A. VP |
23.95 USD |
341 Sold |
8,167 USD |
13/08/2025 | 13/08/2025 |
| Marucci Anthony S CEO |
26.82 USD |
11,500 Bought |
308,430 USD |
11/11/2024 | 11/11/2024 |
| Martin Samuel Bates VP |
35.42 USD |
17,172 Sold |
608,315 USD |
14/06/2024 | 14/06/2024 |
| Crowley Elizabeth VP |
34.87 USD |
30,000 Sold |
1,045,962 USD |
14/06/2024 | 14/06/2024 |
| Young Diane C. CMO |
35.26 USD |
45,000 Sold |
1,586,844 USD |
07/06/2024 | 07/06/2024 |
| Crowley Elizabeth VP |
35.06 USD |
15,000 Sold |
525,873 USD |
07/06/2024 | 07/06/2024 |
| Wright Richard M. CCO |
33.99 USD |
19,264 Sold |
654,695 USD |
03/06/2024 | 03/06/2024 |
| Heath-chiozzi Margo VP |
33.65 USD |
58,369 Sold |
1,964,088 USD |
03/06/2024 | 03/06/2024 |
| Jimenez Freddy A. VP |
33.60 USD |
8,006 Sold |
269,002 USD |
03/06/2024 | 03/06/2024 |